Rödel, F., Sprenger T., Kaina B., Liersch T., Rödel C., Fulda S., Hehlgans S. (2012) Survivin as a prognostic/predictive marker and molecular target in cancer therapy, Current Medicinal Chemistry, 19, 3679-3688


Kaina B., Christmann M., Eich M., Roos W.P. (2012) Survival and death strategies in cells exposed to genotoxins, Issues in Toxicology, No 13, chapter 4.1., 215 et seqq


Huelsenbeck S.C., Schorr A., Roos W.P., Huelsenbeck J., Henninger C., Kaina B., Fritz G. (2012) Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons, Journal of Biological Chemistry, 287, 38590-38599

Faust D., Al-Butmeh F., Linz B., Dietrich C. (2012) Involvement of the transcription factor FoxM1 in contact inhibition, Biochemichal and Biophysical Research Communications, 426, 659-663


Mosby T.T., Cosgrove M., Sarkardei S., Platt K.L., Kaina B. (2012) Nutrition in adult and childhood cancer: role of carcinogens and anti-carcinogens, Anticancer Research, 32, 4171-4192


Christmann M., Kaina B. (2012) O6 -methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke, Mutation Research736, 64-74

Mangerich A., Veith S., Popp O., Fahrer J., Martello R., Bohr V.A., Bürkle A.  (2012) Quantitative analysis of WRN exonuclease activity by isotope dilution mass spectrometry, Mechanisms of Ageing and Development133, 575-579


Nikolova T., Hennekes F., Bhatti A., Kaina B. (2012) Chloroethylnitrosourea-induced cell death and genotoxicity: cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ, Cell Cycle, 11, 2606-2619


Lillich M., Che X., Weil T., Barth H., Fahrer J. (2012) Streptavidin-conjugated C3 protein mediates the delivery of mono-biotinylated RNAse A into macrophages, Bioconjugate Chemistry, 23, 1426-1436


Meise R., Tomicic M.T., Kaina B., Christmann M. (2012) The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells, Biochimica et Biophysica Acta, 1823, 1199-1207


Bauer M., Goldstein M., Heylmann D., Kaina B. (2012) Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant, PLoS One, 7, e39956


Henninger C., Huelsenbeck J., Huelsenbeck S., Grösch S., Schad A., Lackner K.J., Kaina B., Fritz G. (2012) The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity, Toxicology and Applied Pharmacology261, 66-73


Döhrmann M., Schorr A., Hülsenbeck J., Rasmussen T.L., Issinger O.G., Fritz G. (2012) Comparative analysis of stress responses of H9c2 rat cardiomyoblasts following treatment with doxorubicin and tBOOH, Experimental Cell Research, 318, 779-788


Faust D., Schmitt C., Oesch F., Oesch-Bartlomowicz B., Schreck I., Weiss C., Dietrich C. (2012) Differential p38-dependent signalling in response to cellular stress and mitogenic stimulation in fibroblasts, Cell Communication and Signaling, 10:6

Albers A.E., Chen C., Koeberle B., Qian X., Klussmann J.P., Wollenberg B., Kaufmann A.M. (2012) Stem cells in squamous head and neck cancer, Critical reviews in Oncology/Hematology81, 224-240

Koeberle B., Pieé-Staffa A. (2012) The molecular basis of cisplatin resistance in bladder cancer cells, Interchopen.com265-290

Huelsenbeck S.C., Rohrbeck A., Handreck A., Hellmich G., Kiaei E., Roettinger I., Grothe C., Just I., Haastert-Talini K. (2012) C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury, Neurotherapeutics, 9, 185-198